Author: Haviv Y.S.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.19, Iss.1, 2000-01, pp. : 79-81
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Polyzos A. Tsavaris N. Kosmas C. Petrikos G. Stamatiadis D. Kalahanis N. Giannopoulos A. Karatzas G. Sfikakis P.P.
Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. :
Reactions Weekly, Vol. 1, Iss. 1141, 2007-01 ,pp. :
By Estève M.-A. Devictor-Pierre B. Galy G. André N. Coze C. Lacarelle B. Bernard J.-L. Monjanel-Mouterde S.
European Journal of Clinical Pharmacology, Vol. 63, Iss. 1, 2007-01 ,pp. :
Methotrexate is an effective treatment for adult patients with moderate-to-severe atopic eczema
Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. :
Methotrexate pulmonary toxicity
By Lateef Omar Shakoor Najia Balk Robert A
Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. :